Long
Drones and Virtual Reality - A Spec Play
Shares of ARTX look interesting as a speculative play for longer-term investors. The company is in the fields of drones and virtual reality, with recent contract wins with the US military.
At 3 dollars and change, it's a cheap way to play on the long-term growth in those areas, which are bound to see strong growth for some time.
Immediate support lies at $3.35, with additional support below at $3.10 and then $2.70. Upside targets are $3.75 and then the highs at $4.35, or +10% and +28%, respectively from today's close.
I jumped in via calls, specifically the February 2019 $2.50's (currently I.T.M.), paying $1.15 for them. Breakeven comes at $3.65, or 7.4% higher from here... and being so far out, there's plenty of time for this to work.
It may grow in to an investment after I can dig in deeper to fundamentals. I'll update this as more info is known to me. For now, consider it for a spec play or at least keep it on the radar!
Happy trading!
At 3 dollars and change, it's a cheap way to play on the long-term growth in those areas, which are bound to see strong growth for some time.
Immediate support lies at $3.35, with additional support below at $3.10 and then $2.70. Upside targets are $3.75 and then the highs at $4.35, or +10% and +28%, respectively from today's close.
I jumped in via calls, specifically the February 2019 $2.50's (currently I.T.M.), paying $1.15 for them. Breakeven comes at $3.65, or 7.4% higher from here... and being so far out, there's plenty of time for this to work.
It may grow in to an investment after I can dig in deeper to fundamentals. I'll update this as more info is known to me. For now, consider it for a spec play or at least keep it on the radar!
Happy trading!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.